HR tech firm Rippling raises new funding at $16.8 billion valuation, no IPO plans
reuters.com
Want to monitor MLTX?
Get notified when price crosses targets, volume spikes, or RSI hits oversold
Create free account to monitor MLTXmoonlake immunotherapeutics ag is a clinical-stage biopharmaceutical company leveraging revolutionary nanobody® technology to develop next-level medicines for immunologic diseases, including inflammatory skin and joint diseases.